Enleofen Bio logo

Enleofen Bio jobs and careers

Singapore

As of October 24, 2026, Enleofen Bio has no open roles listed.

About Enleofen Bio

Enleofen Bio is a biotechnology company that focuses on developing first-in-class antibody therapeutics for the treatment of fibrotic human diseases. Following the breakthrough discovery in the importance of interleukin 11 as a main driver of fibrosis, Enleofen was founded as a spin-out from National Heart Centre Singapore, SingHealth and Duke-NUS Medical School with Series A funding to translate research findings into treatments that will improve and save the lives of millions of patients worldwide. We aim to develop our lead antibodies in clinical trials within a two-year time frame with the goal of creating a drug that can be used to treat multiple diseases for which there are currently no treatment options. You can find out more about Enleofen by visiting our website at https://www.enleofen.com/.

Founded in 2017 by Andrew Khoo, Jeffrey Lu, Sebastian Schäfer and Stuart Cook.

Founded
2017
Employees
1 to 10
Headquarters
Singapore

Leadership

The top of Enleofen Bio's org chart, with how many people report into each leader.

SS

Sebastian Schäfer

Co-Founder

Enleofen Bio jobs: common questions

Is Enleofen Bio hiring right now?
Enleofen Bio has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Enleofen Bio's careers site.
Where is Enleofen Bio headquartered?
Enleofen Bio is headquartered in Singapore and was founded in 2017.
Who leads Enleofen Bio?
Sebastian Schäfer, Co-Founder, is at the top of Enleofen Bio's org chart.
How do I apply for a job at Enleofen Bio?
Pick a role on Enleofen Bio's TheJobsMap page and select Apply. Every listing links to the original posting on Enleofen Bio's own careers site, so you apply directly with the employer.